Jump Financial’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$940K	Buy	+73,340	New	+$934K	0.01%	955
2025 Q4	–	Sell	-275,992	Closed	-$4.77M	–	2180
2025 Q3	$4.77M	Sell	275,992 -180,609	-40%	-$2.22M	0.06%	424
2025 Q2	$4.28M	Sell	456,601 -47,208	-9%	-$388K	0.05%	465
2025 Q1	$3.58M	Buy	503,809 +141,172	+39%	+$1.43M	0.05%	415
2024 Q4	$4.23M	Buy	362,637 +175,885	+94%	+$2.74M	0.09%	301
2024 Q3	$3.84M	Buy	+186,752	New	+$4.31M	0.08%	297
2024 Q2	–	Sell	-52,560	Closed	-$1.45M	–	2115
2024 Q1	$1.45M	Buy	+52,560	New	+$1.46M	0.04%	599
2023 Q4	–	Sell	-14,295	Closed	-$452K	–	2087
2023 Q3	$452K	Buy	+14,295	New	+$555K	0.02%	1079
2023 Q1	–	Sell	-67,192	Closed	-$2.34M	–	1909
2022 Q4	$2.34M	Buy	67,192 +58,840	+705%	+$2.8M	0.12%	226
2022 Q3	$467K	Sell	8,352 -64,048	-88%	-$3.97M	0.02%	921
2022 Q2	$3.75M	Buy	72,400 +27,846	+62%	+$1.41M	0.16%	173
2022 Q1	$3.24M	Buy	44,554 +33,831	+315%	+$2.87M	0.14%	180
2021 Q4	$1.27M	Sell	10,723 -1,077	-9%	-$135K	0.08%	314
2021 Q3	$1.58M	Buy	+11,800	New	+$1.79M	0.11%	199
2021 Q1	–	Sell	-5,400	Closed	-$294K	–	1178
2020 Q4	$294K	Buy	+5,400	New	+$196K	0.05%	606